The combined company will operate as “Gyre Therapeutics, Inc.” with its common stock traded on Nasdaq under trading symbol “GYRE” effective Tuesday, October 31, 2023 SAN DIEGO, Oct. 30, 2023 (GLOBE ...
CORAL GABLES, Fla., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (CPRX) announced today that it has commenced an underwritten public offering of $150,000,000 of its common stock.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results